• Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


342.0 JPY 9.0 2.56%

As of 02:00:00 ET on 08/21/2014.

Company Profile for AnGes MG Inc (4563)

AnGes MG, Inc. develops gene-therapy drugs that use Hepatocyte Growth Factor (HGF) for myocardial infarction and arteriosclerosis patients. The Company also develops nucleic acid drug (decoy oligo) for patients with asthma, allergy, and rheumatism. AnGes MG develops vectors (a carrier used to introduce a foreign gene into a host cell) which help study and analyze genetic functions.

Contact Information

AnGes MG Inc

7-7-15 Saitoasagi
Osaka, 567-0085
Phone: 81-72-643-3590

Key Executives for AnGes MG Inc (4563)

Ei YamadaPresident/CEOShunsuke SamiExecutive Vice President
Makoto SekiExecutive OfficerTakahiro NakazawaExecutive Officer
Sadayoshi YamanamiExecutive Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil